Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (3166)	3/29/1998 10:47:00 PM
From: Bruce Rosen	Respond to of 7041

<<What makes you think that Vasomax can remain a competitive alternative in the year 2000?>> First, Vasomax may have some advantages in terms of onset of action, side effects and cost. Second, if Viagra is only effective for a smaller percentage of men then the optimistic numbers currently being thrown around, those who are not helped by it may very well try Vasomax. Third, it could be used in combination with Viagra, Muse or some other drug. Fourth, according to Joe Podolski, Zonagen is currently working on a combination of Vasomax with a phosphodiesterase inhibitor. In two years, they could be making progress on that front.